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Abstract

The neurotransmitter deficiency hypothesis suggests that neurotransmitter imbalance is
the physiologic cause for mental health conditions like depression and anxiety. With up to 90%
of serotonin produced in the gut, it is of particular interest whether diet may influence this
balance. The current research seeks to identify a connection between one’s intake of
microbiome-influencing foods/beverages and mental health status. The hypothesis of the study is
that participants who regularly consume greater amounts of pre/probiotic foods will have a
decreased prevalence of depression and anxiety, relative to those who rarely consume
pre/probiotic foods. Differences in survey data were not statistically significant, although they do
suggest that participants who more regularly consumed pre/probiotic foods were less likely to
exhibit depression or anxiety. Similarly, participants with depression or anxiety had higher rates
of antibiotic use. While gut health is likely to be implicated in mental and systemic health, it is
becoming increasingly evident that there is not a simple or single route to cure mental illness
through this connection. A host of genetic, environmental, and lifestyle factors exert great
influence on a person's gut and overall health, and these modalities should be considered in
unison when developing a mental health treatment plan.
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Chapter 1 - Introduction

The current state of mental health in our country could be considered a crisis; every year,
cases of depression and anxiety rise with no single treatment option being efficacious for all
patients. In 2017, the National Institute of Mental Health estimated that 17.3 million, or 7.1%, of
Americans had experienced a major depressive episode at least once (NIMH 2019). The current
treatment options for depression and anxiety are vast but many are hesitant to seek help due to
either the cost of care or negative history with treatment attempts. Mental illness is unfortunately
not well understood and neither are the treatment options for these diseases. With only a 60-70%
complete remission rate with traditional treatments like prescription drug SSRI’s (selectiveserotonin-reuptake-inhibitors), many people resist treatment because it either hasn’t worked in
the past, or there is some other barrier to accessing it. The bottom line is that mental health
concerns are growing while effective treatment options aren’t keeping up with these trends.
For decades, researchers have been investigating alternative treatment methods for
conditions like anxiety and depression. A premature and yet promising area of interest includes
the gut microbiome, where approximately 90% of serotonin and other neurotransmitters are
synthesized. Neurotransmitters are powerful chemical messengers that allow the human body to
communicate with and regulate itself. These unique molecules are responsible for the symphony
of physiological and psychological reactions that occur throughout the nervous system.
Serotonin, dopamine, and epinephrine are some of the most commonly recognized
neurotransmitters, due to their influence on human mood, feelings, and emotions. A fine balance
of these neuro-chemicals are known to award us feelings of happiness and positivity, while
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imbalanced levels could tip us to the other end of the spectrum - into depression and other mood
related disorders.
Generally, serotonin is considered the regulatory neurotransmitter that coordinates
functions such as sleep, mood, appetite, and memory. These critical functions are often disturbed
during depressive or anxious states. In a study by Keszthelyi et al.,(2013), participants with IBS
(Irritable Bowel Syndrome) showed decreased amounts of mucosal serotonin, suggesting that
decreased serotonin concentration in the gut may underlie irritable bowel symptoms.
Alternatively, Irritable Bowel Syndrome and other gastrointestinal irritability issues are common
symptoms associated with patients suffering from anxiety and depression. With many lines of
research on the gut microbiome and mental health criss-crossing at the point of serotonin
utilization and production, tremendous amounts of research have begun to examine and search
for a connection between these two topics once viewed as unrelated.
The gut microbiome functions as an independent, living system with trillions of microbes
living communally within our intestines (Lloyd-Price, Abu-Ali, & Huttenhower, 2016). This
microbiome consists of a diverse collection of gut flora that communicate and behave as a
secondary nervous system. With the digestive tract being a critical line of defense against
pathogens, the enteric nervous system must communicate quickly and effectively with the brain,
and it does this via the Vagus nerve. This bidirectional connection allows the brain and the gut to
send messages back and forth to each other, but to still function independently. Research has
shown that this mighty community is highly sensitive to its environment, suggesting that what
we consume (whether it be food, drugs, or other substances) has an immense impact on the
function of our gut microbiome. Subsequently, what we consume could affect our gut’s ability to
produce significant molecules necessary for central nervous system balance (i.e.,
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neurotransmitters). This suggests that the human diet could exert a direct influence on our mental
health status.
This thesis paper will examine the gut microbiome and mental health connection, and
discuss the potentially harmful impact of gut-destructive diets and substances (such as
antibiotics) on mental health, and review the current literature suggestive of environment-related
mental health treatment interventions and preventions. In addition, novel research will be
presented, examining the connection between dietary intake of foods that would be expected to
influence natural gut bacteria (i.e., prebiotics and probiotics) and one’s mental health status,
specifically the presence of clinical depression and anxiety. The survey hypothesis predicted that
participants who regularly consumed greater amounts of food expected to enhance the gut
microbiome would have a decreased prevalence of depression and anxiety, relative to those who
rarely consumed pre/probiotic foods. The current study suggests that, though not statistically
significant, diets richer in microbiome enhancing foods are associated with lower prevalence of
depression and anxiety.

6

Chapter 2 - Literature Review

The Mental Health Crisis
What we do and don’t know about the cause for mood disorders
For many years mental health conditions (specifically depression and anxiety) were
considered purely psychological, or in other words, “All in our heads”. Many believed that those
experiencing depression could simply turn off the switch (figuratively speaking) and resolve
their depressive episodes by choice. Ask any depressed person if they’d opt for the choice to
simply “unplug” their depression, and undoubtedly most, if not all people suffering from
depression or anxiety would opt for this ability.
Fortunately over the last several decades, physiological explanations have been explored
and presented regarding the pathophysiology of depression. Many believe that there is an
element of genetic predisposition, however, at this time there is no known biomarker to identify
those at risk (Liu, Liu, Wang, Zhang, & Li, 2017). For now, the most widely accepted
hypothesis, the neurotransmitter or monoamine deficiency hypothesis, states that imbalanced
concentrations of neurotransmitters in the brain lead to disparities in mood, motivation, and
overall bodily function; depression is a systemic condition. More specifically, the
neurotransmitter serotonin is believed to exhibit the greatest influence on human mood and
emotion, and therefore is most often studied in regards to depression and anxiety, which are
classified as mood disorders.
The neurotransmitter/monoamine deficiency hypothesis was presented after researchers
unintentionally found that substances that inhibit the reuptake or metabolism of certain
neurotransmitters (serotonin) exhibited antidepressant effects (Liu 2017). The basic
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interpretation of this discovery is that a lack (or insubstantial amount) of serotonin available in
the synaptic cleft could result in depression and therefore, if the reuptake or metabolic processes
that draw serotonin from the synaptic cleft were inhibited, more serotonin would be available to
the synapse and somehow prevent or treat depression. This is evidenced by decreased serum
serotonin levels in depressed patients compared with healthy patients, and again in postmortem
studies on depressed and suicidal patients (Liu 2017).
Alas, this explanation is fairly straightforward and simple to comprehend, and therefore
has been widely accepted by medical professionals as the leading explanation for misunderstood
mental health disorders like depression and anxiety. Because of this, many pharmacological
antidepressant treatments target the brain and the neurotransmitters available to it, and have
generally shown success or at least potential for mild relief from depressive/anxious symptoms.
For now, this is the best explanation we have and hopefully over time, more research will present
alternatives and further our understanding of these complex diseases.
What researchers still don’t know is whether the issue with the serotonin resides in poor
signaling pathways, poor presynaptic release of the neurotransmitter or dysfunction of the
receptors on which serotonin functions (Liu 2017), or another mechanism entirely. Simply put, if
the physical availability of serotonin is point A, and the treatment of depression is point B, we
know both points exist but don’t completely understand how to get from point A to point B, or
even fully how they are connected. While the exact mechanisms are unclear, the current
understanding holds that serotonin synthesis in the gut occurs via enterochromaffin cells (EC).
These are specialized neuroendocrine cells that produce gastric acids, histamine, and aid in the
production of serotonin which is further utilized systemically for many natural processes. Some
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of these uses include promotion of hemostasis, regulation of secretory and motor function within
the enteric (gastric) nervous system, and immune response (Yano et al., 2015).
Due to the poor understanding of the mechanisms involving the neurotransmitter
deficiency hypothesis, many scientists have brought the claim under fire and have made efforts
to disprove or invalidate it. In a perspective article published in World Psychiatry by Cowen &
Browning in 2015, serotonin as a single cause for depression is called into question and chastised
as a “conspiracy theory”. This article references past studies in which diet manipulation through
tryptophan (a precursor to serotonin) depletion showed a correlation between patients with a
history of depression and an increased likelihood to become briefly depressed again under
tryptophan deficient circumstances (Cowen et al., 2015). The significance of this study
demonstrated that tryptophan depletion was not likely to trigger a depressive episode in a person
that had never had one before, suggesting that it is not simply the quantity of available serotonin
or serotonin precursors that perpetuates depression, but a more complex mechanism entirely.
This may even further suggest that once someone has experienced a depressive episode, they are
more likely to experience another (under tryptophan deficient conditions) compared to someone
that has never been depressed before.
And yet, many are still dissatisfied with the lack of answers and knowledge there is to be
had about the causes and treatments for mental health disorders. While we have hypotheses that
are generally accepted, they are not proven claims that withstand all circumstances. For many,
antidepressant medications that are considered the golden standard for depression treatment
don’t work. For many, major depressive episodes (MDE) are unpredictable and not caused by
stressful life events or circumstances. For many that can predict these MDEs as a result of
stressful life circumstances, the depressive symptoms may still linger once the perceived stress is
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resolved. Additionally, there are many people that experience the same stress or endure “worse”
circumstances than someone that suffers from depression, and will not become depressed at any
point in their life. Why is it that some people experience untreatable, uncontrollable depression,
while others don’t and never will? This is a rapidly expanding topic of research with many
promising predictions and studies.

Pharmacological treatment options for depression and anxiety
The monoamine/neurotransmitter deficiency hypothesis laid the groundwork for today’s
frontline treatment options for depression and anxiety. While many researchers have cautioned
against extrapolating the understanding of depression as a simple lack of serotonin to treating it
with drugs that increase availability of serotonin, the results are still significant.
Selective serotonin reuptake inhibitors are antidepressants that do exactly as their name
implies - inhibit the reuptake of serotonin in the synaptic cleft. The chemical and biological
understanding of this complicated process is still somewhat poorly understood and missing
information, however, it seems to work fairly well. Studies critical of antidepressant drugs will
say “only” 60-70% of patients that use SSRIs experience complete remission from major
depressive episodes (Liu 2017), but this is actually quite an impressive response rate. The
aforementioned article by Cowen et al., (2015) describes the effect of SSRIs on the brain as an
emotional relearning tool by effectively redirecting the brain to interpret external stimuli in a
positive manner rather than negatively. This concept claims that (actively) depressed individuals
tend to negatively interpret emotional stimuli which negatively contributes to their overall mood.
By improving the way someone with depression interprets emotions, this shift in bias indirectly
affects mood. The SSRI improves emotional processing.
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Another common antidepressant is the MAOI, or monoamine oxidase inhibitor, and it
works by inhibiting the enzyme that removes neurotransmitters from the brain. The basic
function of the MAOI is congruent with SSRIs, working to increase the amount of serotonin and
other neurotransmitters in the brain. Though effective, MAOIs are unfortunately highly
interactive drugs and can cause dangerously high blood pressure when combined with a variety
of other drugs and foods containing tyramine . Some foods containing tyramine include aged
cheeses, wine, fermented foods, and cured meats, which requires undesirable lifestyle changes
for many adults. MAOIs also interact with certain pain medications, cold and flu medicine, and
herbal supplements. Due to the plethora of restrictions imposed on someone utilizing an MAOI,
they are not a very popular choice of antidepressants.
The most common reason people tend to deny or stop taking an antidepressant is because
of the amount of time it takes for effects to be felt, if any. SSRIs typically take several weeks or
even months to take effect and there is no way to predict on an individual basis how someone
will be affected by them. There is also conflicting evidence regarding SSRI use during
pregnancy, which is a concern for many women considering drug treatment for depression.
Additionally, SSRIs are very sensitive drugs, requiring a strict schedule of daily dosing or they
may otherwise be ineffective or cause side effects. In one study, 23% of suicide victims were on
an antidepressant at the time of death, suggesting a potential lack of efficacy of these drugs
(Karch, Logan, McDaniel, Parks, & Patel, 2012). Furthermore, while SSRIs claim to be effective
in 60-70% of cases, only one third of patients will have success with the very first antidepressant
they try (Gerhard, Wohleb, & Duman, 2016). Many people have to try multiple medications
before finding one that works, and those that aren’t able to find an effective drug get labeled with
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treatment resistant depression (TRD). For those with severe depression and/or suicidal ideation,
spending months to years finding an effective treatment option may not be possible.
While there are most definitely a variety of antidepressant medications available to those
suffering from depression, anxiety, and other mental illnesses, we need more options that don’t
require strict dosing schedules, delayed efficacy, or risk to fetal tissues.

The Gut-Brain Axis: the Brain and the Microbiome
The gut-brain-axis has garnered lots of attention over the last several decades, and
rightfully so. This unique connection is unparalleled in other systems of the human body. The
gut-brain-axis refers to an incredibly interconnected system in which the brain and intestinal gut
are able to communicate bidirectionally with each other through the gut microbiota and
innervation of the intestinal wall. While many nerve connections are involved in this high-tech
communication system, the Vagus nerve (cranial nerve X) garners the spotlight. The Vagus
nerve is arguably the most significant nerve in the human body, as it regulates almost all
parasympathetic functions. Basic bodily functions that we don't have to actively think about, like
breathing, heart rate, and digestion, all fall under the control of cranial nerve X. So while the
brain communicates to the gut, and sustains the subconscious drive to breathe, and ensures that
the heart continues to beat at the right time, all of these systems and organs talk back to the brain
via the Vagus nerve’s direct line.
The Vagus nerve also extends its role beyond basic parasympathetic function to regulate
more complex activities like immune response, gastrointestinal motility, and even endocrine
function (Breit, Kupferberg, Rogler, & Hasler, 2018). What makes the gut-brain-axis so unique
is that while physically connected via the Vagus nerve, the gut is still able to function
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independently even if the nerves connecting it to the brain are severed. This suggests that the gut,
and more broadly the internal organs, are not subject to complete regulation by the brain but
instead are regulated independently and utilize bidirectional control of the central nervous
system.
The Vagus nerve has traditionally been studied from an efferent standpoint, however, in
recent years the studies have shifted to understanding the Vagus nerve as an afferent connection
(Breit 2018). This further solidifies the claim that the brain is more likely to be reliant on
feedback from the internal organs for systemic function than it is a sole dictator of the body.
With such a finely tuned connection between the brain and the gut, many have questioned the
possibility of a stronger influence from “bottom-up” than previously thought...but where does
this influence come from? The answer to this question likely resides in the microbiota of the
enteric nervous system.
While most imagine the immune system to be an invisible, strong defense mechanism
that patrols the body looking for invaders, many don’t realize that a majority of the immune
system resides within the gut! With up to 500 million neurons embedded in the gastrointestinal
wall (Breit 2018), the gut acts as a primary line of defense against pathogens; and thanks to the
Vagus nerve, is able to communicate this at lightning speed to the brain. The gut takes
everything that we consume, whether it be a cheeseburger, an NSAID, or a virus, decodes its
degree of threat to the human body, and shoots a report up to the brain along the Vagus nerve. If
the substance is recognized as harmful, the brain can communicate back to the many different
control centers along the nerve. It can either fire up the immune system to fight back, instruct the
stomach to vomit, or increase intestinal motility resulting in diarrhea.
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The microbiome, microbiota, or “gut bugs” are considered the anchor of the gut-brainaxis. Some scientists have even coined the term “microbiota-gut-brain-axis” to emphasize the
importance of the microbiome on the brain-gut connection. The microbiome is a living and
functioning city, factory, and organ of different microbes that work to interpret our foodstuffs
and send messages up to the brain. You can think of the gut and the brain as two different
people, speaking two different languages, and the microbiota are the translators allowing for
effective communication.
There are trillions of different microbes, and over 1000 different species (Bull &
Plummer, 2014) of bacteria living within the human gastrointestinal tract, some of which are
recognizable by name (e.g., E. coli, C. difficile). While our initial reaction may be to cringe at the
thought of traditionally “harmful” bacteria comfortably making themselves at home in the
intestines, these mighty microbes are actually hard at work regulating and monitoring bodily
health. We live symbiotically with our gut microbiota, with both entities dependent on the other
for good health and survival. However, since the microbiome is composed of living biological
organisms, it is sensitive and susceptible to harm.
So, what do bacteria and nerve connections have to do with mental health? The bottom
line with all of this information is that while everyone has been questioning solely the brain's
functional role in depression, many fail to see that the brain may not be the first stop on the route
to a cure for depression, anxiety, and other mood disorders. We are learning more and more that
the brain is not simply a dictator, but a member of the democracy of the human body, in which
every other organ has a say in systemic health. While a majority of healthcare providers and
researchers focus on only the brain's role in mental health conditions, many forget that not only
does the brain rely on the gastrointestinal tract for 90% of the body’s serotonin, but the gut also
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talks to the brain every second of every day. The unanswered question that remains asks, “Well,
what is the gut saying?”

The Pathology of Two Interconnected Systems: Discussion of the Gut-Brain-Axis in
relation to depression and anxiety
The significance of the human gut microbiome cannot be overstated. The brain and gut
not only communicate bidirectionally, but they communicate and influence each other through
the autonomic nervous system, endocrine system, immune system, and enteric nervous system.
These are four major control forces within our bodies that quite literally dictate survival. When
the immune system is compromised, we develop infections and fevers and illness. When the
neuroendocrine system is impaired, so is our ability to reproduce, regulate blood sugar,
metabolize foods, utilize energy, and more. Damage or changes in the gut microbiome may
influence conditions like IBS, metabolic and autoimmune conditions, and even neuropsychiatric
disorders (Evrensel & Ceylan, 2015). When multiple systems are connected so intricately, we
should consider the likelihood that all of these systems manipulate and influence each other. The
gut microbiota exert influence on each and every one of these systems, which makes it shocking
that our gut is still not one of the first areas of interest when addressing mental health concerns.
In general, it seems that the individual is often held responsible or criticized for gut
associated illness - society is quick to blame dysbiosis on a person's life choices, without
considering genetic and uncontrollable environmental influence. However, with as much
influence as the gut has on our many bodily systems, and reversely those systems on the gut, it is
imperative that we understand how external factors impact gut health as well. Humans can incur
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damage to their gut microbiota pre- and postnatally from antibiotics, as well as during delivery,
and even by the way parents choose to breast or formula feed their children. These critical points
in gut microbiome development may be outside of individual control, yet significantly impact
long term gut health. We cannot discount the claim that diet exerts a strong influence on gut
strength, but we must acknowledge that there are other profound predispositions in the overall
equation as well.

Prenatal and Pediatric Implications
There are many decisions to be made when expecting a baby. What you will name her,
where he will attend school, what kind of lifestyle you want to provide. No parent dreams of
subjecting their children to Irritable Bowel Syndrome, and frankly these predispositions are not
often within parental control. While a crash c-section, or GBS (Group B. Streptococcus)
infection is not always avoidable, the impact that these conditions bestow upon newborn babies
is multifaceted and worth mentioning in the overall scheme of gut development. After learning
about the intricacies and complexities of the human gut microbiome, many assume that its
maturity and development occur parallel to the host, reaching full maturity in early adulthood.
This is far from the truth!
The gut develops in three distinct stages - the developmental stage (months 3-14),
transitional stage (months 15-30), and reaches the stable stage by month 42, which is
approximately three and a half years old (Stewart et al., 2018). Before a child even enters
kindergarten, their gut microbiome is almost fully developed and will not change much, in a
foundational sense, even into their adult years. A study by Yatsunenko even claims that the gut
microbiome becomes indistinguishable from an adult composition by the age of three years old

16

(Yatsunenko et al., 2012). This further emphasizes the importance of early gut health promotion
in any way possible; vaginal delivery, breastfeeding even for a short amount of time, and
avoiding antibiotics if at all possible during pregnancy and in early years of life are all proven
methods of microbiome promotion. This is critically important information because as time goes
on, we learn more and more that gut health is founded early in life. If microbiome establishment
occurs as early as we think, and if the microbiome is as heavily implicated in mental health as we
suspect, then early health decisions like these can truly impact the foundations of mental health
stability for our children.

Delivery Method
Evidenced by differing overall microbial concentrations in babies delivered vaginally
compared to cesarean section, the newborn gut microbiome is highly dependent upon the
mother’s overall health and method of delivery (Reyman et al., 2019). Babies that are born via
cesarean section show decreased microbial diversity for up to two years after birth, which is a
problem because as mentioned previously, gut microbiome diversity is the single most important
factor in maintaining a healthy microbiome. Decreased microbial diversity due to c-section is
especially an issue as it is correlated with respiratory infections, as well as asthma, in children
(Magnus et al., 2011). When delivered vaginally, babies travel through the birth canal, and are
exposed to all sorts of microbial flora, which is their first introduction to the external world. Csections require babies to be removed directly from the mother’s uterus, denying this early
colonization that is so important for gut and overall microbiome development.
Reyman and colleagues highlighted that microbiome diversity at 1 week of age is directly
associated with the number of respiratory infections acquired in the first year of life (Reyman
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2019). This means that the less diverse the microbiome (due to c-section), the greater the risk
that an infant will acquire a respiratory illness in their first year of life. The Klebsiella species are
most often associated with respiratory infections and this species is found abundantly in children
delivered by c-section . This predisposes them to respiratory illness, furthering the claim that csections are associated with suboptimal infant health.
Furthermore, a 9-year study with the Norwegian Mother and Child Cohort found that
infants delivered via c-section demonstrated a 20% increased risk of developing asthma later in
life, compared to vaginal deliveries. In addition to this, 22% of children with asthma at 36
months old also experienced recurrent lower respiratory tract infections (Magnus 2011). These
studies indicate that the delivery method is indeed an important factor in the future health of the
infant; remember that the gut microbiome is nicknamed the enteric immune system due to its
influence on the systemic immune system, and this is an example of one of the first ways that
this becomes evident.

Feeding Method
Infants lack the basic immune strength to fight pathogens that would otherwise be cleared
in an adult body, putting them at high risk for exposure illness. Luckily, babies that are breastfed
acquire passive immunity from their mothers, which essentially transfers protection from mother
to child via breastmilk (Cacho & Lawrence, 2017). While the mother is breastfeeding, the infant
should receive immune protection from antibodies found in breastmilk. Immune stimulation is
not the only benefit of breastfeeding. In addition, children that are breastfed have a lower risk of
developing type 1 and 2 diabetes, decreased obesity rate, decreased morbidity and mortality rate
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due to gastrointestinal illness, reduced risk of asthma, and may even show superior cognitive
development (Daly, Pollard, Phillips, & Binns, 2014). It is important to note that the passive
immunological protection is only available while breastfeeding and once the mother stops, the
passive transfer of immune benefit does as well.
Bringing it back to the gut-brain axis, this is yet another example of how diet impacts the
overall immune system. We know that breastfeeding directly affects the microbial composition
of children's gut microbiome by comparing mother to child microbial makeup and noting a
strikingly common composition in fecal samples (Jost, Lacroix, Braegger, Rochat, & Chassard,
2013). Mothers transfer microbes directly to their babies’ guts through breastmilk, which directly
benefits their gut development. Alternatively, formula-fed infants are at an increased risk of
developing a life threatening infection called Necrotizing Enterocolitis (NEC), which results in
destruction of the bowel wall. Is it coincidence that breast milk alternatives can, quite literally,
destroy an infant’s gastrointestinal system? The bacteria that causes NEC can survive in the nonsterile environment of dry formula and has been found to grow there (Savino et al., 2015). Most
importantly, babies that are formula fed are not supplied with the immunoglobulins in breast
milk that provide passive immunity (Cacho 2017), and are put at greater risk of developing
varied illnesses, including Necrotizing Enterocolitis, due to this lack of protection.
The data regarding breastfeeding influence on long term mental health outcomes should
be considered inconclusive. Some studies show positive long term impact on prevalence of
depression (de Mola, 2016; Reynolds, 2016) , and some show no correlation (Kwok, 2013;
Anselmi, 2008). A recent study in 2016 showed that individuals who were breastfed for greater
than 6 months experienced less depressive symptomatology in adulthood, compared to those that
were breastfed for less than 6 months (de Mola et al., 2016). These results were amplified with

19

longer periods of breastfeeding. Another study found that children observed at age 9, who were
breastfed through infancy, were 26% less likely to score in the abnormal range of psychological
adjustment compared to non-breastfed peers (Reynolds, Hennessy, & Polek, 2016). This
publication is congruent with previous studies in pediatric and adolescent populations.
Breastfeeding may be a more predictive factor in young populations, and show less influence
over time as adolescents and adults become independent and exhibit different lifestyle choices.
Many studies supporting breastfeeding as a preventive measure in mental health can be found,
but there seems to be limited, if any, research conducted on relationships between formula fed
infants and later mental health issues. While the literature seems to support breastfeeding as a
long term mode of protection from many illnesses and conditions, more studies are needed
before confirming feeding method as a causative factor in these issues.
And yet, not everyone is able to have a vaginal delivery, or breastfeed their baby, or
avoid antibiotics. This section is not intended to serve as a lesson in prenatal care
recommendations, it is simply included to emphasize the significance of infantile early
interactions with food, its environment, and long term implications of these exposures. Poor gut
health may not be solely related to individual decision making, but rooted even further back in a
person's health history.

Antibiotics - a compromise for mental health?
The microbiome is an incredibly strong system and utilizes many mechanisms of
protection. One of these methods is the ability of bacteria within the microbiome to prevent
overpopulation of competitors through production of an antimicrobial substance called
bacteriocin (Bull 2014). This substance allows “local” community bacteria to get rid of
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destructive “tourist” species that are unwelcome. Even without bacteriocin, the many species of
microbes within the gut survive in a Darwinist manner, which may overpower harmful strains so
that the beneficial strains may prevail. All species of bacteria in the gut have specific,
differentiated roles and the responsibility to protect the community. While the gut microbiome
can function like a perfectly oiled machine, if the entire team isn’t working together, or if the
factory is overrun by employees that don’t want to work, the machine can’t and won’t run
effectively. When treated with antibiotics, lots of employees get wiped out, making it very
difficult for the factory to function efficiently.
Given the delicate sensitivity of the microbiota-gut-brain axis, it’s not surprising that
drugs like antibiotics can damage the microbiome and lead to systemic effects. The purpose of an
antibiotic is to kill bacteria - in all cases, this is the desired outcome. Antibiotics are utilized to
clear infections, and these wonder-drugs were prescribed like candy when medicine discovered
how many infections could be resolved simply by killing the bacteria that caused them. In time,
we learned that antibiotic treatment comes with a host of side effects and potential long term
consequences. Antibiotic-resistant bacteria can cause a superinfection, which is a secondary
infection that occurs after someone has been treated for a prior infection. A superinfection occurs
after antibiotics kill off a majority of the protective bacteria that reside within the gut, leaving the
GI tract defenseless against resistant bacteria that were not destroyed by the antibiotic. This leads
to a host of complications, and due to the resistance of said bacteria to antibiotics, is very hard to
treat. The most common side effects associated with antibiotics tend to be gastrointestinal nausea, vomiting, and diarrhea. These are also the predominating signs of a damaged gut
microbiome, and when the microbiome is damaged, so can be the connection between all of the
other organs that depend on biofeedback from the gut.
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Scientists have since discovered that broad spectrum antibiotics cannot differentiate
between helpful and harmful bacteria, and often destroy (or greatly reduce) the diversity and
amount of good bacteria that occur naturally in the intestinal tract, despite wanting to maintain
them (Liang, Wu, Hu, Wang, & Jin, 2018). Antibiotics that only kill specific strains of bacteria
are considered “narrow spectrum” but cannot be used unless the specific bacterial strain causing
an infection is identified. Often, this takes time and resources and with particularly aggressive or
risky infections, time is of the essence. Not to mention that sometimes, the specific bacterial
offender cannot be identified, rendering a broad spectrum antibiotic the only viable option.
Ultimately, the use of antibiotics is known to result in the destruction of overall microbial
diversity in the gut - a diversity that the entire body is dependent on.
When you consider a person that has been treated many times with antibiotics, it becomes
apparent that their gut microbiome is unlikely to be in the best working order. Take it a step
further and evaluate someone who was repeatedly prescribed antibiotics as a child for ear
infections, urinary tract infections and more, some would say that individuals like this may have
never even developed a fully mature microbiome. Antibiotics are incredibly strong anti-infective
substances, which is why they are so heavily used in medicine. Unfortunately, the aftermath of
antibiotic treatment is not short-term, taking several weeks to months, if ever, to repair a gut that
has been exposed to an antibiotic. In a study by Palleja et al.,(2018), twelve men underwent a 4day course of antibiotic treatment with meropenem, gentamicin, and vancomycin. After one and
a half months post-treatment, their microbial concentrations had returned to almost baseline, with
the complete inability to detect 9 species of beneficial microbes that had been detectable prior to
treatment. Studies like these emphasize that while antibiotics are incredibly effective at clearing
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infections, we ultimately run the risk of good and healthy microbes getting caught in the
crossfire.
Recall that the microbiota translate messages between the gut and the brain
bidirectionally - and therefore, if these mighty microbes are destroyed or “injured”, those critical
messages cannot be relayed as effectively. This is the underlying concept between microbiome
health and mental health. Large scale studies have demonstrated that the use of antibiotics
increases the risk of developing depression and other psychiatric symptoms (Liang 2018), due to
the sensitive connection between the gut and brain. These results are even more strongly
correlated with timing and dosage; the longer the treatment, and the greater the dose of
antibiotics that one receives, the greater their risk of developing undesirable mental health
symptoms, even 10 years after completing the regimen. Though the evidence with human trials is
fairly preclinical, there is still likely a connection; we just aren’t quite sure of the mechanisms
that cause them.
One proposition for the biological mechanism behind antibiotic-induced psychiatric
events arises from evidence that the microbiota can influence the activation of CNS glial cells
(Hao, Li, Zhang, & Chen, 2020). Glial cells (astrocytes and microglia) are heavily responsible
for nervous system repair and regeneration, and are thought to be implicated in the pathogenesis
of depression through neurotransmitter reuptake. Remember that one of the predominating
hypotheses for the biological basis of depression is the issue with insufficient or inadequate
neurotransmitter supply (recall selective serotonin reuptake inhibitors). When glial cells are
overactivated, depressive behaviors can be observed. Antibiotics have been shown to activate
glial cells in the brain, which can result in depressive symptoms, suggesting that glial stimulation
could be a mechanism for antibiotic-induced depression (Guida et al., 2018). Additionally,
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studies show that rats treated with antibiotics show lowered hippocampal serotonin levels
concurrent with depressive-like behavior, indicating that antibiotics may damage the serotonin
production centers in the gut (Hoban et al., 2016).
While the implications of antibiotics as a causative factor in depression in animal studies
have come into the spotlight in recent years, many criticize the extrapolative efforts to suggest
these same implications in humans. Fortunately, a decent amount of results have been published
evidencing a likely association between antibiotic treatment and depressogenic effects in
humans. In 2010, a 75 year old man lacking history of depression or more broadly, mental
illness, committed suicide after being treated with antibiotics for a post-op wound infection (Hao
2020). The cause of the man’s suicide was listed as result of an acute depressive episode he
endured related to the antibiotics levofloxacin and trimethoprim sulphamethoxazole. This is one
of the first times in history that an antibiotic was considered in the cause of death by suicide.
Subsequently in a 2016 survey, Kaur et al., showed that of 94 participants, 93 of them reported
experiencing depression (62%) or anxiety (72%) post antibiotic treatment. In the United States,
as of 2017, 17.3 million people (7.1%) had experienced at least one depressive episode (NIMH
2019).
In a post-partum depression study, correlations between depression 1-2 months
postpartum and intrapartum antibiotic treatment were suggested (Murphy, Paul, Dunlop, &
Corwin, 2018). The EPDS (Edinburgh Postnatal Depression Scores) of the women who had
taken antibiotics intrapartum were significantly higher at 1-2 months postpartum, compared to
those who had not. There was also no significant difference between the experimental and
control group during the typical 14 day postpartum “baby blues” period, indicating that the
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postpartum depression was diagnosable depression and not simply “baby blues”. This
relationship was not significant at the 3-6 month follow up.
Research assessing pediatric outcomes after antibiotic use showed that children who
received antibiotic treatment before one year of age were more likely to demonstrate
significantly lower intelligence test scores, and increased scoring in behavioral difficulties
(Slykerman et al., 2016). Furthermore, those that received antibiotics during the first year of life
showed more profound ADHD and depressive symptomatology’s by 11 years old, compared to
those that hadn’t received antibiotics this young . Even at an early age, we begin to see the
potential effects of a damaged or underdeveloped gut microbiome. Psychiatric symptoms
become evident, behavioral issues surface, and if the microbiota hypothesis is correct, these risks
could be reduced or even eliminated if we simply made more gut-promoting choices.
Fortunately, contrasting studies have shown improvement in psychiatric conditions when
patients were treated with probiotics (independent of antibiotic use), which are foods and
substances that contain live cultures of bacteria that replenish the gut (Evrensel 2015). In recent
years, prescribers have begun to recommend that patients taking antibiotics incorporate probiotic
foods (e.g., Greek yogurt, kefir, kimchi, and other fermented foods) into their diets to combat the
gut-damaging effects of the antibiotics. This suggests that the gut is directly associated with the
brain and mental health; by demonstrating that antibiotics can destroy the microbiota, and may
implicate psychiatric symptoms, and probiotics reverse or reduce these symptoms, we see that
the gut microbiome plays a significant role in our mental health status. More on this in
subsequent discussions.
Antibiotics may never be recognized as a direct clinical cause for psychiatric symptoms,
however, they most definitely could be listed as a predisposing factor. Maybe not alone, but with
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a history of previous antibiotic treatment, and a less than perfect gut microbiome, a less than
satisfactory diet, and any number of predisposing factors discussed previously, antibiotics may
be yet another push towards the depressive and anxious end of the mental health spectrum.

The Western Diet as a Contributor to First-World Chronic Illness
Categorized as a high fat, high sugar, and low fiber eating pattern, the Western diet
consists mostly of pre-packaged and preserved foods for convenience and easy access. Despite
the relative convenience of processed foods, there is a high cost associated with this ease of
access, making it difficult for underdeveloped countries to acquire these food options.
Alternatively, developed countries like the United States have the appropriate infrastructure to
rapidly produce new processed foods and make individual sales affordable for the average
consumer. Interestingly enough, the most modernized countries that adhere to the Western diet
are those with some of the highest rates of IBD, chronic illness, asthma, obesity, and
cardiovascular disease (Statovci, Aguilera, MacSharry, & Melgar, 2017). Many propose that
these eating habits are to blame for the host of illnesses accompanying modern lifestyles, and if
this is the case, healthcare may not be able to keep up with the amount of disease that we will see
in the near future.
The microbiome is highly sensitive and susceptible to change. Some of the most diverse
changes that occur within our bodies are due to the foods we eat, drugs we consume, and
lifestyle choices we make. Anything that passes through the gut has an effect on it, whether it be
positive or negative and our diet is especially critical. Most of the nutrients we need as humans
come from our diet, so the importance of what we are eating cannot be underestimated. Of
importance to mention are short chain fatty acids (SCFAs), which are the result of our gut
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bacteria’s fermentation and metabolism of dietary fiber and a main energy source for host
colonocytes (den Besten et al., 2013). Fiber (and subsequent SCFAs) have been shown to
improve metabolic syndrome, and decrease the risk of IBS/D, cardiovascular disease, diabetes,
and certain cancers. In mouse models, mice that are fed high fat/high sugar diets show altered
microbiota composition, increased inflammation, more gut permeability, and a reduction in fecal
SCFA concentration (Agus et al., 2016). Inflammation is the body’s natural response to protect
against injury, infection, and other illness and therefore, whenever inflammation is noted or
caused by a certain substance, there is a certain level of suspicion that should arise. Why would
our gut enact the same response to certain foods or substances that it would to bodily harm? The
answer may be more obvious than we think.
In a study by David et al.,(2014), participants cycled between plant based and animal
based diets for 5 days at a time. Of importance to note is the fact that the animal based diet
contained no plants whatsoever during the 5-day eating period, only meat and dairy products,
which creates a high-fat environment within the digestive tract. This comparison is intentionally
dichotomous, as it seems that Western diets tend to be animal based with minimal plant products.
The results of the study showed that the concentrations of microbes within the participants'
microbiomes changed in less than 24 hours. Inflammatory bacterial strains multiplied when fed
the animal based diet, and healthy bacterial strains were reduced. Additionally, excessive growth
of a specific bacteria known to produce hydrogen sulfide (which promotes bowel inflammation)
was noted immediately with the animal based diet. Similar results are noted in animal studies
with processed foods, showing that consumption of ultra-processed, high fat foods resulted in
microbial changes and gut inflammation (Shi et al., 2019). Results like these are clinically
significant in demonstrating that the diet has a rapid and measurable impact on the composition
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of the microbiome, which can suggest that eating habits like these over extended periods of time
can cause more substantial, negative changes. The evidence doesn’t stop there; a meta-analysis
of 21 studies across 10 different countries showed that high fat/high animal product diets were
associated with elevated risk of developing depression (Adjibade et al., 2019). Additional
studies from Akbaraly (2009), Sanchez-Villegas (2012), and Jacka (2014) show comparable
results. This demonstrates that diet can not only alter the microbiota, but that these effects may
extend further to microbial related systemic health. Before swearing off fat forever, it’s
important to recognize that there are different kinds of fats and that this is a macronutrient that
the body needs for survival. Just like gut bacteria, there are good fats and bad fats and we can
choose which kinds we want to fuel our body with.
Typically, trans fats and saturated fats are regarded as harmful or unhealthy - they tend to
elevate blood LDL cholesterol levels which is what causes buildup in our vasculature, increasing
risk of stroke and heart attack. Furthermore, high intakes of saturated fats have been correlated
with depression in human studies, meanwhile higher unsaturated fat intakes have shown to do
quite the opposite, increasing desirable HDL cholesterol and decreasing the incidence of
depression (Fernandes, Mutch, & Leri, 2017). This concept can even be taken a step further,
evidenced by a study conducted by Liu et al. (2016). Young patients suffering from major
depression and control participants with no history of depression submitted blood samples for
comparison. The results showed a correlation between blood phospholipid levels and incidence
of depression, and even furthermore, the greater the blood phospholipid level, the worse the
depression tended to be. While this correlation does not show causation, a blood phospholipid
sample could be diagnostic or at least suggestive of a risk factor for major depression. It is
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becoming more and more evident that there is unlikely to be one specific biomarker or test that
will confidently diagnose depression.
The nervous system contains the second highest concentration of fat aside from adipose
tissue stores - this means that fat is incredibly important for CNS maintenance and function. This
is evidenced by impaired emotional behavior when fatty acid compositions in the brain are
altered (Fernandes 2017). The body naturally produces the types of fat that are easily consumed the only two fatty acids that humans require from an exogenous source (i.e. diet) are ⍺-linolenic
and linoleic acids. Polyunsaturated fats (PUFAs) are most abundantly found in foods like fatty
fish, dark green and leafy vegetables, seeds, and nuts - all foods that are often limited in the
standard American or Western diet. And interestingly enough, a deficiency in PUFAs has been
associated with altered dopaminergic and serotonergic neurotransmission in the rat brain, which
may be implicated in depression (Fernandes 2017). It appears that it is not simply the overall
intake of fats that contribute to poor health outcomes, but more specifically which type of fats
are consumed.
While researchers cannot confirm the exact mechanisms by which specific nutrients
induce diet-related depression, many suspect that non-nutritive additives and supplements like
artificial sweeteners and preservatives may play a role (Adjibade 2019). Aspartame, a common
artificial sweetener, is metabolized in the gut to produce aspartic acid and phenylalanine
(Choudhary & Lee, 2018). Both of these metabolites cross the blood brain barrier, and work to
reduce dopamine and serotonin in the brain. Recalling the neurotransmitter deficiency
hypothesis, this effect could have many implications on the utilization of neurotransmitters
within the brain resulting in neuro-physical symptoms like headaches, irritability, anxiety,
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depression, or insomnia. This is very novel research and should be pursued in more human
studies prior to making clinical decisions based on these early findings.

Western Medicine and Recognizing Gut Health as a Pillar in Systemic Health
The food that we consume has an immeasurable impact on our overall health, but for
some reason, we aren’t trained to initially consider diet or gut health as a main pillar of systemic
health. Symptoms like constipation, diarrhea, and indigestion are all obvious signs of poor gut
function, but so are symptoms like fatigue, brain fog, difficulty with concentration, and mood
imbalance. Neuropsychiatric conditions like Alzheimer’s, Schizophrenia, ADHD, Anxiety,
Depression, migraine headaches, and Multiple Sclerosis (just to name a few) all have
implications with diet related symptom management (Umbrello & Esposito, 2016). Poor gut
health doesn’t just result in stomach upset, it upsets the entire body. With the increased rate of
antibiotic prescribing in the past, the introduction of highly processed foods, and lack of general
population knowledge on the impact of diet on overall health, it’s no wonder that general health
is where it is today.
Treatment-based medicine is the gold standard curriculum in most modern medical
programs. A patient with type 2 diabetes is seen regularly for medication regimen check-ins,
blood work, and physical exams, all to determine whether their disease is progressing or being
maintained. Chronic illnesses like diabetes, obesity, and heart disease are all issues of metabolic
discourse, or in other words, lifestyle diseases that can be preventable given the right timing and
type of lifestyle change (Zhao & Shen, 2010). Other chronic illnesses like depression, anxiety,
and other mental illnesses often walk hand in hand with these related physical health issues and
might also be preventable with improved “whole person” health care.
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The medical model is the standard of practice by which medical doctors assess, diagnose,
and treat patients. In brief, this method of care supports evidence based medicine, through
utilization of diagnostic tools and biomedical data, along with subjective data, to determine a
diagnosis based on clinical evidence (Swaine 2011). This raises an issue because the medical
model emphasizes a difference between physical and psychiatric health, putting these two pillars
of health in separate categories, rather than considering them holistically. Many can agree that
physical health plays a big part in mental state and vice versa, but with the current methods of
diagnosing mental illness through subjective data and little to no biological diagnostic tools, the
idea of physical and mental health as separate categories is made more evident. Of course, these
lines have become more blurred in recent years as we have learned more about the mutual
inclusivity between physical and mental health, but hopefully in the future there will be no lines,
and no gray areas regarding the interplay between physical and mental health.
Another issue is that the healthcare and reimbursement systems are more likely to cover a
treatment like antidiabetic medication or antidepressants than allotting coverage to preventative
options like genetic testing, access to fitness centers, high quality food reimbursement, or mental
health care for everyone. According to the CDC, as much as 90% of the United States’ yearly
spending on healthcare ($3.5 trillion) goes towards treating chronic and mental health conditions
(CDC 2020). Imagine how healthcare, the economy, and individual lives would change if even a
small portion of that money could be spent on preventing these illnesses from ever occurring,
rather than trying to play catch up after onset.
In recent years, many physicians, psychiatrists, and other healthcare providers have been
urged to consider gut health in the bigger picture of a patient's overall condition. Not only do
providers ask their patients what they are eating, but they are cutting back on antibiotic
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prescriptions, improving patient education around topics such as gut-brain health, and including
dietitians in patient care where diet may be a source of illness. While these are all great steps,
they are not enough and the health of our people will depend on their choices, and efforts to not
get sick. So what is all of this leading up to?
The discovery of the gut microbiome has led to the understanding that there are two
genomes within the human body - that which is genetically inherited and the other that is the
human microbiome, which is dependent on environmental exposure for development. Composed
of 90% microbes and 10% human cells, we are highly dependent on our microbiome for
survival, development, for gene expression, and for passing this genetic influence on to future
generations (Zhao 2010). Knowing this, we understand that though we are born with an inherited
genetic code, the human microbiome exerts immense influence upon that code and even is
capable of altering genes and their expression. The significance of this is slightly beyond the
scope of this review, however, one can appreciate the power of the environment and its influence
on our delicate health throughout the human experience. While the human genome is quite rigid,
the human gut microbiome is quite flexible as discussed previously. What we consume, breathe,
and apply to our skin, all has an individual and profound effect on our overall health and must be
considered as such. Changes in the microbiome composition and metabolism will undoubtedly
have an impact on the host - this is why we need to value gut health right alongside the standard
physical exam.
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Potential Alternatives to Pharmacological Interventions for Mental Illness
Alas, we’ve made it to the solution section. By this point, it should be clear that there is
no single, one stop fix to mental health conditions through manipulation of the gut-brain axis.
From the way a person entered the world, to the way they feed and medicate themselves, every
input from the environment has an effect on the way a person's body functions and interprets
information. What cures one person’s depression may ignite it in another, which is why this gutbrain-axis discussion is such a difficult topic to pursue in medicine, psychiatry, research, etc. As
of now, there are only 2 known methods to positively influence the gut microbiome towards the
stable, healthy end of the spectrum and these are consumption of pre/probiotics and fecal
microbiota transplant.

Prebiotics & Probiotics
Prebiotics and probiotics - these are terms that have become well-known in today's health
and diet industries, and for good reasons! Pre/probiotics are food nutrients that positively
influence the gut microbiota. We know that the microbes living within our digestive systems are
living organisms, and living organisms need to eat. Simply put, prebiotics are food for gut bugs
and probiotics are new family members we provide to established gut bugs. Probiotics are live,
active cultures that you would (hopefully) naturally find if you took a sample from your own
microbiome. We can find probiotics in fermented foods like yogurt, kimchi, sourdough bread,
kombucha, and sauerkraut just to name a few. Getting probiotics from the diet allows for the
replenishment of lost microbial strains, or strengthening current ones by adding sheer numbers to
the overall composition. Prebiotics are what feed those living cultures that do so much good, and
they can be found in fiber-rich foods like fruits, vegetables, and whole grains. Our intestinal
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microbiota helps our gut to function at its best, so consuming prebiotics and probiotics is one of
the most effective ways to strengthen and repair the gut. Probiotics colonize our intestines, and
have shown many therapeutic benefits in common gastrointestinal disorders (Wallace & Milev,
2017) but it wasn’t until recently that probiotics were suggested as preventative and treatment
options for neuropsychiatric conditions as well.
Researchers are beginning to label pre/probiotic foods as “psychobiotics” to stress the
connection between psychiatric and microbiome impact. Human and animal research has shown
an alleviation in depressive and anxiolytic symptoms when participants are treated with
psychobiotic substances (Akkasheh, 2016; Benton, 2007; Burokas, 2017; Desbonnet, 2010;
Wallace 2017). The evidence of depression in germ-free (GF) rats (a decrease in mobility during
a forced swim test) is even reversed when inoculated with a single bacterium, Bifidobacterium
infantis (Desbonnet et al., 2010). In the study by Desbonnet, rats were given either citalopram
(an SSRI antidepressant) or Bifidobacterium infantis and forced swim test behaviors, blood
samples, and neurotransmitter levels were monitored. Both the citalopram and the B. infantis,
when compared to controls, improved depressive behaviors and influenced positive biochemical
changes in the rat blood samples. Studies in GF mice have shown that the microbiome is an
essential contributor to neurological development, especially in the areas of anxiety behavior and
social responses (Bruce-Keller, Salbaum, & Berthoud, 2018). Additionally, the study conducted
by Desbonnet et al. (2010) found that serum tryptophan (serotonin precursor ) increased after
consumption of a probiotic supplement, suggesting that not only the overall diet but specifically
the type and amount of probiotics consumed, may have a direct effect on the nervous system and
neurotransmitter synthesis. This is groundbreaking information as currently, the best hypothesis
for the physiological explanation for depression relates back to neurotransmitter imbalance. If
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what we eat can directly or even indirectly influence the molecules that send messages between
the brain and the gut, we might have an alternative route for mental health treatment.
In a study by Burokas et al., (2017), their prebiotics of choice (fructooligosaccharides and
galactooligosaccharides) were able to alter behavior and brain chemistry indicative of depression
and anxiety in mice. More clearly, the mice exhibited antidepressant effects after chronic
prebiotic exposure. Another interesting finding from this study showed that specific bacterial
strains that tend to be reduced during periods of chronic stress were maintained through prebiotic
exposure, even under chronic stress, suggesting that prebiotic supplementation could prevent
subsequent systemic effects that often result in altered mental health status. These microbial
changes also led to increases in SCFAs, which is ultimately the goal of gut metabolism (Burokas
2017). It appears as though supplementation with pre and probiotic substances may even be an
alternative route of anxiety and depression treatment, at least when considered in mice and rat
models.
Across five studies performed on human patients with mood disorders, three out of five
of those studies reported an improvement in mood after treatment with a probiotic (as reviewed
in Wallace 2017). In a double blind trial with 124 otherwise healthy participants, the group
reporting depressed mood showed a significant improvement in self-reported mood after only 20
days of probiotic treatment (Benton, Williams, & Brown 2007). A similar placebo-controlled
trial with forty MDD (Major Depressive Disorder) patients indicated that the experimental group
that was given the probiotic drink showed marked improvement in depressive symptoms
compared to the placebo group which received an indistinguishable placebo with no probiotic
bacteria (Akkasheh et al., 2016). All of these results are congruent with the claim that utilizing
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pre and probiotics to repair the gut microbiome can have a deeper effect on the gut-brain axis,
and more specifically, the gut’s relationship with mental health.
While it may be easy to put full confidence into the possibility of a straightforward gutbrain connection, and subsequent treatment possibilities, the success stories mentioned
previously are not always repeatable in further studies. A double blind, placebo controlled study
in 2015 failed to show a significant difference in Positive and Negative Syndrome Scale
(PANSS) or GI function between patients with schizophrenia and controls that were both treated
with probiotic supplements (Dickerson et al., 2014). Results are often stronger and more easily
repeated in studies conducted with healthy patients, suggesting that it’s easier to make a healthy
person healthier but it is not as simple to correct more serious issues. Probiotics also have shown
impressive medical results in patients with GI related conditions, but until we see similar results
on the psychiatric side of the equation, more research is needed to determine whether
psychobiotics could be used as a promising alternative to antidepressant or antianxiety
medications. Given these considerations, an interesting realm of research could examine
psychobiotics as a preventative measure in healthy patients as a means of depression and anxiety
prevention, especially in those with a family history of these disorders. Since probiotics seem to
be helpful in patients that are relatively healthy to begin with, it would be interesting to conduct
long term follow up studies on participants that routinely implement psychobiotic foods in their
diets to evaluate rates of new depressive/anxious symptoms.

Fecal Microbiota Transplant
Fecal microbiota transplant (FMT) is exactly as the name implies - a transplant of fecal
matter from one person to another. While this intervention may seem complicated and
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unorthodox, it is actually quite simple. The underlying concept of fecal microbiota transplant
comes from the understanding that healthy microbial contents differ from unhealthy
microbiomes. Though FMT is still considered a fairly experimental treatment, it yielded a 94%
success rate in clearing C.difficile infections in one study, compared to 31% efficacy with
Vancomycin antibiotic treatment (Groen & Nieuwdorp, 2017). These numbers attracted attention
to the treatment and have encouraged its implementation in C.difficile cases. Feces from a
healthy donor is transferred to someone with a C.difficile infection - a gastrointestinal infection
of the microbiome in which healthy bacteria is killed off by a more sinister pathogenic bacteria.
C. difficile infection results in an array of unpleasant symptoms, such as diarrhea, nausea, fever,
loss of appetite, and abdominal pain. Through a FMT, a healthy stool which contains healthy
microbes, is donated to the recipient to help fight off and replace the pathogenic bacteria
responsible for the infection. The good bacteria are able to reclaim and recolonize the gut, while
also clearing out the bad bacteria. After recognizing the relative successes of fecal transplant,
scientists questioned whether FMT could be used for more than just C.difficile infections.
This is exactly what Kootte and colleagues wondered when they conducted a FMT study
on obese males with metabolic syndrome (Kootte et al., 2017). Fecal matter was obtained from
lean, healthy donors and transferred to obese participants. This resulted in improved glucose
metabolism and altered microbial composition at 6 weeks after the treatment. This research is
extremely relevant due to the fact that donors transferred physiological health changes directly to
the recipients through fecal matter. This indicates that the microbiome is capable of adapting and
utilizing exogenous microbes for physiologic functions, which further supports the positive
health outcomes of consuming probiotic foods which contain live cultures, of course assuming
that these live cultures can withstand the harsh environment of the early GI tract.
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Expanding on this even further, fecal microbiota composition is notably altered in
depressed patients, suggesting that there is a functional and gut microbial composition difference
between depressed and non-depressed individuals, furthering the association between the gut and
brain health (Jiang et al., 2015). Another study found that when GF mice were colonized with
microbiota from human participants with Major Depressive Disorder, depressive behavior was
subsequently observed. Control groups exhibited the expected response, showing no depressive
behavior when colonized with healthy microbiota (Zheng et al., 2016), suggesting again that
physiological health can be transferred between patients through FMT. While the Jiang (2015)
study did in fact show a notable difference in gut microbial composition in depressed patients
versus healthy patients, these results are not necessarily congruent or suggestive of a positive
association between differing microbial composition and depression.
The microbiome is unique to every individual and may not necessarily correlate with
other health problems. Many further studies will have to be conducted to identify specific
bacterial strains that may or may not contribute to depressogenic behaviors. While we have
observed in many previous studies that the microbiota has a strong ability to transfer
physiological health from one person to another, the long-lasting effects of these observations are
unknown. Patients that recover from C.difficile thanks to FMT may owe their initial recovery to
the microbes that played a part, but ongoing health may not necessarily be a result of the initial
transplant.
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Chapter 3 - Methods

Due to the role of the gut microbiome in serotonin production and utilization, and
understanding the potential implications of serotonin on depression and anxiety, novel research
was conducted to determine whether there was a relationship between participants’ diet,
antibiotic use, and past diagnosis of anxiety or depression. Participants completed an
anonymous online survey (Appendix A) in which they answered questions regarding their mental
health status and dietary habits. Those that answered “yes” to a prior diagnosis of clinical anxiety
or depression were presented with 10 questions regarding their current treatment of these
disorders, dietary habits, and recent antibiotic use. Those that answered “no” to a diagnosis of
clinical anxiety or depression were presented with 6 questions regarding their dietary habits and
recent antibiotic use (Figure 1). University Human Subjects Review Committee approval was
obtained prior to dissemination of the survey (Appendix B).
The survey was available for 10 days, through an online link that was shared directly with
EMU College of Health and Human Services program students, as well as varied science majors
(i.e., Biology, Psychology, Chemistry). Participation included a one-time completion of the
survey and was estimated to take 5 minutes to complete. Data was analyzed by Chi Square test
using IBM SPSS Statistics 24, to examine relationships between a diagnosis of anxiety or
depression (or lack thereof), and other lifestyle choices/health outcomes.
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Figure 1. Question Sequence based on respondent answers.
All respondents began the survey with Question 1, and based on their responses received
different questions regarding their diagnosis, lifestyle choices, and health outcomes.
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Chapter 4 - Results

Overall, 638 responses were collected from the online survey with a 12.7% total response
rate (of 5023 email addresses). Across all measures, there were no statistically significant
differences between those with and without a diagnosis of anxiety/depression identified.
However, based on raw data, those without a diagnosis consumed more prebiotic/probiotic foods
on a weekly basis and were less likely to have ever taken an antibiotic, compared to those that
had been diagnosed with anxiety and depression (Figures 2-5). Of the respondents without a
diagnosis, 76% consumed prebiotics more than once a week, 64% consumed probiotics more
than once a week, and 7% had never used an antibiotic. Of those participants with a diagnosis of
anxiety or depression, 72% consumed prebiotics more than once a week, 60% consumed
probiotics more than once a week, and only 4% had never used an antibiotic. While these
differences are small and were not statistically significant, the data trends support the hypothesis
that those who consume more gut enhancing foods, and avoid antibiotics, are less likely to
exhibit depression and anxiety. The remainder of data collected from the survey is presented in
Tables 1-8.
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Figure 2. Comparison of prebiotic intake between diagnosed and undiagnosed respondents

Rate of Weekly Probiotic Intake
70.00%
60.00%
50.00%
40.00%
30.00%
20.00%
10.00%
0.00%

1X/WEEK OR LESS
■ No Diagnosis

GREATER THAN ll(/WEEK
■ Diagnosis

Figure 3. Comparison of probiotic intake between diagnosed and undiagnosed respondents
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Figure 4. Comparison of antibiotic use based on diagnosis of depression/anxiety
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Figure 5. Comparison of antibiotic use in the last year based on diagnosis of depression/anxiety
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Yes

No

251 (40%)

387 (60%)

131 (59%)

117 (41%)

112 (86%)

18 (14%)

Have you been clinically diagnosed (by a
physician, psychiatrist) with Major
Depressive Disorder/Depression (MDD) or
Generalized Anxiety Disorder/Anxiety
(GAD)?
Are you currently taking pharmaceutical
medications for treatment/maintenance of
either of these disorders?
Do you feel as though your medication
regimen has improved your condition?

Table 1. Diagnosis of anxiety or depression and pharmaceutical drug use and perceptions of
improvement in those diagnosed.
SSRI

SNRI

Other

90 (70%)

13 (10%)

26 (20%)

Please select which type of medication
you are using to treat/maintain your
condition

Table 2. Types of medications used by participants diagnosed with anxiety or depression

44

More than 1 year

1 year or less

82 (62%)

50 (38%)

How long have you been using
medication to treat/maintain your
condition?

Table 3. Length of medication usage in those diagnosed with anxiety or depression.
Never
When was the
last time you

Within

Within

Within

Greater

the last 6

the last

the last 2

than 2

months

year

years

years ago

took/received
antibiotics?

Diagnosed

9 (4%)

88 (36%)

45 (18%)

48 (20%)

54 (22%)

Undiagnosed

24 (7%)

100 (27%) 66 (18%)

76 (20%)

106 (28%)

Table 4. Most recent antibiotic use among all participants.
Flexitarian
Select the diet

Omnivore

Vegan

Vegetarian

Diagnosed

67 (29%)

145 (59%)

8 (3%)

21 (9%)

Undiagnosed

76 (20%)

271 (73%)

8 (3%)

16 (4%)

that best
applies to you

Table 5. Diet type among all participants.
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Less than

Once per

2-4 times per

once per

week

week

Every day

week
Please rate
how often you
consume a diet

Diagnosis

25 (11%)

42 (17%)

100 (42%)

72 (30%)

Undiagnosed

28 (8%)

58 (16%)

161 (44%)

120 (33%)

Every day

rich in
prebiotic foods/
ingredients

Table 6. Prebiotic consumption among all participants.

Please rate
how often you

Less than

Once per

2-4 times per

once per

week

week

week

consume a diet
rich in
probiotic

Diagnosis

102 (42%)

54 (22%)

63 (26%)

25 (10%)

Undiagnosed

134 (36%)

86 (23%)

117 (31%)

37 (10%)

foods/
ingredients

Table 7. Probiotic consumption among all participants.
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Yes

No

Diagnosed

36 (15%)

206 (85%)

Undiagnosed

49 (13%)

323 (87%)

Do you take any kind of
probiotic supplement?

Table 8. Probiotic supplementation among all participants.
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Chapter 5 - Discussion

The novel research for this project attempted to determine whether those with a reported
diagnosis of anxiety or depression were more or less likely to consume gut-microbiome
enhancing foods (i.e., pre and probiotics). While the results were not statistically significant, the
raw data did in fact support the hypothesis that individuals without diagnosed anxiety and/or
depression were more likely to consume gut-microbiome enhancing foods, and were less likely
to have taken antibiotics, compared to the participants that were diagnosed with anxiety or
depression. This information is congruent with consideration to the current literature on these
topics.
The primary interest of this novel research was to determine whether those that consumed
more gut-microbiome enhancing foods were less likely to experience anxiety or depressive
symptoms. A study by Burokas et al., (2017), found that prebiotics were able to alter behavior
and brain chemistry indicative of depression and anxiety in mice. The mice exhibited
antidepressant behaviors after chronic prebiotic exposure. An additional finding from this study
showed that specific bacterial strains that tend to be reduced during periods of chronic stress
were maintained through prebiotic exposure, despite chronic stress, suggesting that prebiotic
supplementation might prevent subsequent systemic effects that often result in altered mental
health status (Burokas, 2017). Furthermore, Desbonnet et al. (2010) found that serum tryptophan
increased after probiotic supplementation. This suggests that overall diet and specifically the
type and amount of probiotics we consume may have a direct effect on the nervous system and
neurotransmitter synthesis. Three out of five studies performed on human patients with mood
disorders reported an improvement in mood after treatment with a probiotic (Wallace 2017).
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Benton et al., (2007) found that in a trial with 124 otherwise healthy participants, the group
reporting depressed mood showed a significant improvement in self-reported mood after 20 days
of probiotic treatment. A similar trial with forty major depression patients demonstrated that the
experimental group given a probiotic drink showed noticeable improvement in depressive
symptoms compared to the control group (Akkasheh 2016). This is congruent with the findings
of the novel research - though not statistically significant, those without a diagnosis of anxiety or
depression consumed more pre and probiotics compared to those with a diagnosis.
A study by Liang in 2018 revealed that use of antibiotics increased the risk of developing
depression and other psychiatric symptoms (Liang 2018), which was a hypothesis of this novel
research - that participants who had used antibiotics would be more likely to exhibit depression
or anxiety symptoms. The Liang study found that the length/timing and the dose of antibiotic
treatment increases one's risk of developing undesirable mental health symptoms, indicating that
even 10 years after treatment, side effects were still notable. If antibiotics are potentially
correlated with depression and anxiety, in the future, this is important information to be aware of
as antibiotic treatment could prolong and pronounce a person's mental health symptoms. While
the results of the novel research are congruent with the literature review findings, it should again
be noted that the results were not found to be significant under analysis.
Major Depressive Disorder (MDD) and Generalized Anxiety Disorder (GAD) are both
multifaceted conditions most likely resulting from a cocktail of genetic predisposition, physical
health status, and environmental input. To only consider one of these pillars in a long term
treatment plan would most likely prove to be ineffective, and therefore, medical and mental
health providers should begin deeper evaluation of chronic MDD/GAD patients to determine a
combination treatment plan. Given the current understanding of microbiome development, an
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interesting area of future research could involve long-term follow up studies regarding pediatric
to adult mental health progression, considering delivery method, infantile feeding methods,
childhood antibiotic use, and general diet habits leading up to adulthood. More research
regarding genetic and environmental predisposition to mental health issues would be valuable.
Diet based interventions hold to be a promising future treatment or even prevention
method for mental illness, however, should not be considered an alternative without thorough
consultation from a physician and dietitian. Given the current research, diet based interventions
should be utilized as a preventative or maintenance measure, alongside other lifestyle
interventions like regular physical exercise, smoking and drug abstinence, ensuring proper sleep
habits, and other long-term health recommendations. Currently, the most effective methods to
restore gut equilibrium are through regular consumption of pre and probiotic foods, maintaining
a “healthy” diet, and, in more severe cases, through fecal microbiota transplant. With
consideration for gut health, foundations of a “healthy” diet include fiber-rich fruits and
vegetables and regular incorporation of fermented foods. The most well-known pre and probiotic
foods contain live and active cultures that are found naturally in our gut microbiome and help
regulate gut equilibrium. By changing our diets, and listening to our bodies, we may be one step
closer to solving the mental health crisis.
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APPENDICES
Appendix A - Novel Research Survey
Survey for which participants HAVE been diagnosed with MDD/GAD

1. Have you been clinically diagnosed (by a physician, psychiatrist) with Major
Depressive Disorder/Depression (MDD) or Generalized Anxiety Disorder/Anxiety
(GAD)?
a. Yes
b. No - redirect to other survey
2. Are you currently taking pharmaceutical medications for treatment/maintenance
of either of these disorders?
a. Yes - proceed to question 3, 4, 5
b. No - disregard question 3, 4, 5
3. Please select which type of medication you are using to treat/maintain your
condition
a. SSRI (selective-serotonin reuptake inhibitor)
b. SNRI (serotonin-norepinephrine reuptake inhibitor)
c. Other (please specify)
4. How long have you been using medication to treat/maintain your condition?
a. 1 year or less
b. More than 1 year
5. Do you feel as though your medication regimen has improved your condition?
a. Yes
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b. No
6. When was the last time you took/received antibiotics?
a. Never
b. Within the last 6 months
c. Within the last year
d. Within the last 2 years
e. Greater than 2 years ago
f. *Please provide name of antibiotic if possible
7. Select the diet that best applies to you
a. Omnivore (you are not restricted in food groups and you regularly
consume meat, dairy products, and plant-based foods)
b. Flexitarian (you are not restricted in food groups but you only eat specific
types of animal meats; i.e., only white meats, no pork, etc, and you
regularly consume meat, dairy products, and plant-based foods)
c. Vegetarian (you do not eat meat but you regularly consume other animal
products like dairy, and also plant-based foods)
d. Vegan (you do not consume meat or dairy products and consume only
plant-based foods)
8. Please rate how often you consume a diet rich in prebiotic foods/ingredients
(prebiotic items include but are not limited to apples, grapefruit, bananas,
asparagus, onions, garlic, leeks, artichoke, chickpeas, lentils, bean varieties,
bran, oats, almonds, flax seeds)
a. Less than once per week
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b. Once per week
c. 2-4 times per week
d. Every day
9. Please rate how often you consume a diet rich in probiotic foods/ingredients
(probiotic items include but are not limited to yogurt, sauerkraut, kimchi, kefir,
kombucha, tempeh, miso, sourdough bread, traditional uncultured buttermilk,
cottage cheese)
a. Less than once per week
b. Once per week
c. 2-4 times per week
d. Every day
10. Do you take any kind of probiotic supplement?
a. Yes
b. No

Survey for which participants HAVE NOT been diagnosed with MDD/GAD

1. Have you been clinically diagnosed (by a physician, psychiatrist) with Major
Depressive Disorder/Depression (MDD) or Generalized Anxiety Disorder/Anxiety
(GAD)?
a. Yes
b. No
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2. When was the last time you took/received antibiotics?
a. Never
b. Within the last 6 months
c. Within the last year
d. Within the last 2 years
e. Greater than 2 years ago
f. *Please provide name of antibiotic if possible
3. Select the diet that best applies to you
a. Omnivore (you are not restricted in food groups and you regularly
consume meat, dairy products, and plant-based foods)
b. Flexitarian (you are not restricted in food groups but you only eat specific
types of animal meats i.e only white meats, no pork etc, and you regularly
consume meat, dairy products, and plant-based foods)
c. Vegetarian (you do not eat meat but you regularly consume other animal
products like dairy, and also plant-based foods)
d. Vegan (you do not consume meat or dairy products and consume only
plant-based foods)
4. Please rate on average how often you consume a diet rich in prebiotic
foods/ingredients (prebiotic items include but are not limited to apples, grapefruit,
bananas, asparagus, onions, garlic, leeks, Jerusalem artichoke, chickpeas,
lentils, bean varieties, bran, oats, almonds, flax seeds)
a. Less than once per week
b. Once per week
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c. 2-4 times per week
d. Every day
5. Please rate on average how often you consume a diet rich in probiotic
foods/ingredients (probiotic items include but are not limited to sauerkraut,
kimchi, kefir, kombucha, tempeh, yogurt, miso, sourdough bread, traditional
uncultured buttermilk, cottage cheese)
a. Less than once per week
b. Once per week
c. 2-4 times per week
d. Every day
6. Do you take any kind of probiotic supplement?
a. Yes
b. No
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Appendix B - EMU Human Subjects Review Committee approval

